The Business Model
Service Contracts
Partnering with other scientific organizations to test industry libraries, leads, and repurposed assets
Collaborative Research
Joint ventures to co-develop assets
Connecting with international partners
Licensing Agreements
Novel use patents for existing assets
Novel COM through screening programme
Operational Plan
-
Build proprietary Drosophila models for curated list of rare diseases
Establish partnerships with pharma and academia
-
Scale up to include mammalian model validation
Develop a pipeline of at least five lead candidates that have the potential to treat genetic diseases
-
Collaborate with patient advocacy groups
Apply for orphan drug designations
Partner with pharma for clinical trials